Observation of Use of Claritin (Loratadine) Tablet, RediTabs, and Dry Syrup in Children (Study P05834)(COMPLETED)
Completed
Merck Sharp & Dohme Corp.
2008-03-01
The purpose of this study is to collect information on unexpected adverse reactions (ADRs),
how often ADRs occur, and factors that can affect the safety and effectiveness of Claritin
(loratadine) when used in children. Patients will be observed while they are taking Claritin,
and ADRs and symptom scores will be recorded. At the end of treatment, improvement in
symptoms will be recorded.
Post-marketing surveys are not considered applicable clinical trials and thus the results of
this survey will not be posted at its conclusion. The results will be submitted to public
health officials as required by applicable national and international laws.
Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
Completed
Pfizer
Phase 4
2001-03-01
The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl
syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11
years old.
Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR)
Completed
Johnson & Johnson Consumer and Personal Products Worldwide
Phase 4
2001-03-01
The objective of this clinical trial was to assess the efficacy and safety of cetirizine HCl
syrup vs. loratadine syrup vs. placebo syrup in the treatment of SAR in children 6 to 11
years old.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
